Related Experiment Videos

Prevalence of anticardiolipin antibodies in various thrombotic conditions: a hospital-based study

S Chandrashekhara1, R Kirthi, Joyce Varghese

  • 1Department of Immunology, MS Ramaiah Medical College, Bangalore.

Insights

Anticardiolipin antibodies (aCL) are a common acquired thrombophilic defect. This study found aCL IgG in 20.77% of patients, with deep vein thrombosis being the most frequent manifestation.

Area of Science:

  • Hematology
  • Immunology
  • Vascular Medicine

Background:

  • Thrombosis is a leading global cause of mortality.
  • Anticardiolipin antibodies (aCL) are recognized as a frequent acquired protein defect contributing to thrombosis.
  • Understanding the incidence of aCL in diverse thrombotic conditions is crucial.

Purpose of the Study:

  • To determine the incidence of anticardiolipin antibodies (aCL) in patients presenting with various thrombotic events.
  • To investigate the association between aCL IgG and specific thrombotic conditions.

Main Methods:

  • Retrospective screening of 302 patients for aCL IgG using enzyme-linked immunosorbent assay (ELISA).
  • Collection of detailed clinical and epidemiological data from patient records and examinations.

Main Results:

  • High titers of aCL IgG were detected in 65 (20.77%) of the 302 patients.
  • Deep vein thrombosis (DVT) was the most common thrombotic event (29.8%), with aCL IgG incidence of 13.79%.
  • aCL IgG was also observed in coronary artery (25.0%), central nervous system arteries (17.21%), and peripheral arteries (18.75%) thrombosis.

Conclusions:

  • Anticardiolipin antibodies (aCL) represent the most prevalent acquired thrombophilic defect.
  • Further epidemiological data specific to the population studied is necessary to refine strategies for thrombosis research in aCL-positive individuals.
Abstract

Related Concept Videos

Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...